✦ LIBER ✦

Prospective Evaluation and Follow-Up of European Patients with Visceral Leishmaniasis and HIV-1 Coinfection in the Era of Highly Active Antiretroviral Therapy

✍ Scribed by J. L. Villanueva; A. Alarcón; M. Bernabeu-Wittel; E. Cordero; D. Prados; C. Regordán; J. Alvar

Publisher: Springer
Year: 2000
Tongue: English
Weight: 53 KB
Volume: 19
Category: Article
ISSN: 0934-9723
DOI: 10.1007/s100960000364

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decline of a visceral leishmaniasis epid

Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART)

✍ R. López-Vélez; J. L. Casado; V. Pintado 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Deletions in env gene of HIV-1 in AIDS p

Deletions in env gene of HIV-1 in AIDS patients treated with highly active antiretroviral therapy (HAART)

✍ Shreesh Saurya; Zelman Lichtenstein; Abraham Karpas 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

## Abstract Many AIDS patients retain high CD4+ T‐cell counts despite a significant increase in PCR viral load after varied periods of treatment on drug combination with Highly Active Antiretroviral Therapy (HAART). In order to investigate this contradictory phenomenon, we assayed for infectious HI

Skeletal muscle involvement in human imm

Skeletal muscle involvement in human immunodeficiency virus (HIV)–infected patients in the era of highly active antiretroviral therapy (HAART)

✍ François-Jérôme Authier; Patrick Chariot; Romain K. Gherardi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Impaired Recovery of CD4+ Cell Counts Fo

Impaired Recovery of CD4+ Cell Counts Following Highly Active Antiretroviral Therapy in Drug-Naïve Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus

✍ J. Macías; J.A. Pineda; F. Lozano; J.E. Corzo; A. Ramos; E. León; J.A. García-Ga 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 263 KB

Long-term evaluation of the efficacy and

Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1-year open follow-up

✍ T. Rentmeester; A. Janssen; J. Hulsman; F. Scholtes; B. van der Kleij; J. Overwe 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 534 KB

The effect and safety of loreclezole were evaluated during a long-term follow-up trial targeting higher plasma concentrations than those of the preceding controlled trial. The result is better than in the double-blind trial, in which loreclezole doses were administered to reach plasma concentrations